Search Results - "Boer, A. de"

Refine Results
  1. 1

    Erosion of Dosage Compensation Impacts Human iPSC Disease Modeling by Mekhoubad, Shila, Bock, Christoph, de Boer, A. Sophie, Kiskinis, Evangelos, Meissner, Alexander, Eggan, Kevin

    Published in Cell stem cell (04-05-2012)
    “…Although distinct human induced pluripotent stem cell (hiPSC) lines can display considerable epigenetic variation, it has been unclear whether such variability…”
    Get full text
    Journal Article
  2. 2

    How sperm competition shapes the evolution of testes and sperm: a meta-analysis by Lüpold, Stefan, de Boer, Raïssa A, Evans, Jonathan P, Tomkins, Joseph L, Fitzpatrick, John L

    “…Females of many species mate with multiple males, thereby inciting competition among ejaculates from rival males for fertilization. In response to increasing…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Identification of actions to be taken by managers to facilitate the return to work of cancer survivors: Consensus between managers and cancer survivors by Porro, B, Tamminga, S.J, de Boer, A. G.E.M, Petit, A, Roquelaure, Y, Greidanus, M.A

    Published in BMC public health (12-10-2022)
    “…Abstract Background Managers are considered to be main stakeholders in the return to work (RTW) of cancer survivors. However, the perspectives of cancer…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Pharmacogenetics: From Bench to Byte- An Update of Guidelines by Swen, JJ, Nijenhuis, M, Boer, A, Grandia, L, Maitland‐van der Zee, AH, Mulder, H, Rongen, GAPJM, Schaik, RHN, Schalekamp, T, Touw, DJ, Weide, J, Wilffert, B, Deneer, VHM, Guchelaar, H‐J

    Published in Clinical pharmacology and therapeutics (01-05-2011)
    “…Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch…”
    Get full text
    Journal Article
  8. 8

    Common risk factors for heart failure and cancer by Meijers, Wouter C, de Boer, Rudolf A

    Published in Cardiovascular research (15-04-2019)
    “…Abstract Cardiovascular (CV) disease and cancer are the leading causes of death.1,2 Over the last decades, it has been appreciated that both CV disease and…”
    Get full text
    Journal Article
  9. 9

    Roles for both FtsA and the FtsBLQ subcomplex in FtsN‐stimulated cell constriction in Escherichia coli by Liu, Bing, Persons, Logan, Lee, Lynda, Boer, Piet A. J.

    Published in Molecular microbiology (01-03-2015)
    “…Summary Escherichia coli FtsN is a bitopic membrane protein that is essential for triggering active cell constriction. A small periplasmic subdomain (EFtsN) is…”
    Get full text
    Journal Article
  10. 10

    Growth of the developing mouse heart: An interactive qualitative and quantitative 3D atlas by de Boer, Bouke A., van den Berg, Gert, de Boer, Piet A.J., Moorman, Antoon F.M., Ruijter, Jan M.

    Published in Developmental biology (15-08-2012)
    “…Analysis of experiments aimed at understanding the genetic mechanisms of differentiation and growth of the heart, calls for detailed insights into cardiac…”
    Get full text
    Journal Article
  11. 11

    Scarcity of Rare Earth Elements by deBoer, M. A., Lammertsma, K.

    Published in ChemSusChem (01-11-2013)
    “…Rare earth elements (REEs) are important for green and a large variety of high‐tech technologies and are, therefore, in high demand. As a result, supply with…”
    Get full text
    Journal Article
  12. 12

    A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect? by de Boer, A.H., Chan, H.K., Price, R.

    Published in Advanced drug delivery reviews (15-03-2012)
    “…Many years of research have not led to a profound knowledge of the mechanisms involved in the formulation and dispersion of carrier based mixtures for…”
    Get full text
    Journal Article
  13. 13

    Population-wide cerebellar growth models of children and adolescents by Gaiser, Carolin, van der Vliet, Rick, de Boer, Augustijn A. A., Donchin, Opher, Berthet, Pierre, Devenyi, Gabriel A., Mallar Chakravarty, M., Diedrichsen, Jörn, Marquand, Andre F., Frens, Maarten A., Muetzel, Ryan L.

    Published in Nature communications (18-03-2024)
    “…In the past, the cerebellum has been best known for its crucial role in motor function. However, increasingly more findings highlight the importance of…”
    Get full text
    Journal Article
  14. 14

    Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease by van der Feen, Diederik E, Bartelds, Beatrijs, de Boer, Rudolf A, Berger, Rolf M F

    Published in Heart (British Cardiac Society) (01-02-2019)
    “…Pulmonary arterial hypertension (PAH) in congenital heart disease (CHD) can be reversed by early shunt closure, but this potential is lost beyond a certain…”
    Get more information
    Journal Article
  15. 15

    Supporting employers to enhance the return to work of cancer survivors: development of a web-based intervention (MiLES intervention) by Greidanus, M. A., de Boer, A. G. E. M., Tiedtke, C. M., Frings-Dresen, M. H. W., de Rijk, A. E., Tamminga, S. J.

    Published in Journal of cancer survivorship (01-04-2020)
    “…Purpose The purpose of this study was to develop an intervention targeting employers, with the aim of enhancing cancer survivors’ return to work (RTW). Methods…”
    Get full text
    Journal Article
  16. 16

    Predictors for earlier return to work of cancer patients by Wolvers, M. D. J., Leensen, M. C. J., Groeneveld, I. F., Frings-Dresen, M. H. W., De Boer, A. G. E. M.

    Published in Journal of cancer survivorship (01-04-2018)
    “…Purpose This study aims to investigate how perceived work ability, job self-efficacy, value of work, and fatigue predict return to work (RTW) in cancer…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Drug targeting to the brain by DE BOER, A. G, GAILLARD, P. J

    “…The central nervous system (CNS) is a sanctuary site and is protected by various barriers. These regulate brain homeostasis and the transport of endogenous and…”
    Get full text
    Journal Article
  19. 19

    Perceived employer‐related barriers and facilitators for work participation of cancer survivors: A systematic review of employers' and survivors' perspectives by Greidanus, M.A., Boer, A.G.E.M., Rijk, A.E., Tiedtke, C.M., Dierckx de Casterlé, B., Frings‐Dresen, M.H.W., Tamminga, S.J.

    Published in Psycho-oncology (Chichester, England) (01-03-2018)
    “…Objective To identify employer‐related barriers and facilitators for work participation of cancer survivors from the perspective of both employers and cancer…”
    Get full text
    Journal Article
  20. 20

    The fibrosis marker galectin-3 and outcome in the general population by de Boer, R. A., van Veldhuisen, D. J., Gansevoort, R. T., Muller Kobold, A. C., van Gilst, W. H., Hillege, H. L., Bakker, S. J. L., van der Harst, P.

    Published in Journal of internal medicine (01-07-2012)
    “…  de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJL, van der Harst P (University of Groningen). The…”
    Get full text
    Journal Article